StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.72+0.00 (+0.43%)

Close on Nov 18, 2026Market cap $8.37MP/E –Yield –

Phio Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Phio Pharmaceuticals's revenue for the twelve months ending Dec 31, 2020 was $0, down 100.0% year over year. For fiscal 2020 it was $0, down 100.0% from the year before. The highest annual figure on record is $399.00K in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$21.00K-84.8%
FY2018Dec 31, 2018$138.00K+820.0%
FY2017Dec 31, 2017$15.00K-21.1%
FY2016Dec 31, 2016$19.00K-44.1%
FY2015Dec 31, 2015$34.00K-91.5%
FY2013Dec 31, 2013$399.00K+311.3%
FY2012Dec 31, 2012$97.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–
Q1 FY2020Mar 31, 2020$0-100.0%
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0-100.0%
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$21.00K-8.7%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$57.00K–
Q2 FY2018Jun 30, 2018$58.00K–
Q1 FY2018Mar 31, 2018$23.00K–
Q4 FY2017Dec 31, 2017$15.00K–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Phio Pharmaceuticals figures

See a number that looks wrong?